AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
Catherine Wilson(University of Oregon), Jeff Settleman(Discovery Centre)
Cited by 145
Related Papers
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
|Cancer Research|2014|308
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibition
|Oncotarget|2014|142
Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
|Oncogene|2013|92
Complete <i>de novo</i> assembly and re-annotation of the zebrafish genome
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2